(HealthDay) -- For some patients with advanced melanoma and brain metastases, ipilimumab is active, according to the results of a phase 2 study published online March 27 in The Lancet Oncology.
Mar 27, 2012
0
0
(HealthDay) -- Anal human papillomavirus (HPV) infection and precancerous lesions are common among gay and bisexual men, but most of these cases will not progress to anal cancer, a new analysis of earlier research shows.
Mar 23, 2012
0
0
Women who use the oestrogen-only form of hormone replacement therapy (HRT) appear less likely to develop breast cancer in the longer term, according to new research published Online First in The Lancet Oncology. A follow-up ...
Mar 6, 2012
0
0
(Medical Xpress) -- Fears that involuntary exposure to chemicals in food and consumer products causes cancer are not supported by evidence, and anxiety about their dangers is diverting attention from proven methods of cancer ...
Feb 28, 2012
1
0
More than three quarters (77%) of cancer patients who first present to their family doctors (GPs) with suspicious symptoms are referred to hospital after only one or two consultations, a new study has found. However, the ...
Feb 23, 2012
0
0
Women with a history of endometriosis are significantly more likely to develop three specific types of ovarian cancer (clear cell, endometrioid, and low-grade serous), according to an article published Online First in the ...
Feb 21, 2012
0
0
Hot flushes and night sweats (HFNS) affect 65-85% of women after breast cancer treatment; they are distressing, causing sleep problems and decreased quality of life. Hormone replacement therapy is often either undesirable ...
Feb 14, 2012
0
0
A study published Online First by The Lancet Oncology, and linked to The Lancet Series on cancer in pregnancy, shows that children of women exposed to chemotherapy while pregnant develop as well as children in the general ...
Feb 9, 2012
0
0
A drug that has been shown to prevent breast cancer in postmenopausal women at high risk of developing the disease, and is poised for widespread use, appears to significantly worsen age-related bone loss, according to an ...
Feb 6, 2012
0
0
In patients with HER2-positive breast cancer, Tykerb (lapatinib) has been used both in combination with herceptin (trastuzumab) and as an alternative single-agent therapy for pre-surgery (neo-adjuvant) chemotherapy treatment. ...
Jan 16, 2012
0
0
